Alternatively, a national circular economy should be developed to enable the sharing of good quality reused products..
His approach to all projects combines high-quality design with an effective and rigorous delivery process in order to exceed the client’s aspirations.The design solutions are both pragmatic and idealistic; utilising the most appropriate construction solutions for each project, whilst realising schemes of great design and aesthetic merit.
The projects undertaken, although diverse in type and scale, are unified by a singular commitment to ensuring logic in the design process.Ian Pegrum joined Bryden Wood in 2013, having worked for multi-national engineering consultancy practices throughout his career.. Ian became a Board Director in 2013 and is responsible for the management of the Building Services Engineering team, as well as for our HR function..He retains a hands-on approach to project work and is responsible for design, construction and commissioning for a wide range of projects.He has extensive experience across a number of sectors including Healthcare, Cultural & Heritage and Sports.. Ian’s specialist discipline is.
electrical engineering., however he has built up considerable cross-disciplinary knowledge while leading many large and complex engineering projects around the world.
More recently, Ian has been involved particularly in a number of.
and residential projects, in the UK and overseas.. For HR, Ian has overall responsibility for all aspects of our employee journey, from recruitment to terms of employment and employee benefits, including our focus on wellbeing and making sure that.He advocates for harnessing digital tools, prefabrication, and industrialised processes to expedite their roll-out.
From designing flexible, modular manufacturing systems to implementing continuous production processes, these approaches can help industries achieve decarbonisation goals faster and more efficiently.. 3.Accelerate Pharma: A platform for cross-sector collaboration.
Jaimie discussed Bryden Wood's role in convening leading pharmaceutical companies, such as GSK, Sanofi, Roche, and AstraZeneca, through the.Accelerate Pharmaceuticals.